GRI Bio

About:

GRI Bio is a biotech company that develops therapies to treat inflammatory diseases.

Top Investors: National Science Foundation

Description:

GRI Bio is a biotechnology company that develops therapies to treat inflammatory diseases. Its cell-based therapies are developed to treat liver disease and autoimmunity deficiencies by targeting the regulation of NKT cells.

Total Funding Amount:

$14.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2009-01-01

Founders:

Marc Hertz

Number of Employees:

1-10

Last Funding Date:

2024-06-27

IPO Status:

Public

Industries: